UC DIS.CERT. 08/24 LOR/ DE000HC3DY00 /
29.05.2024 21:46:06 | Изменение- | Бид21:59:21 | Предложение21:59:21 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
378.750EUR | - | 378.750 Величина цены спроса: 130 |
378.820 Величина цены предложения: 130 |
L OREAL INH. E... | - - | 23.08.2024 | Call |
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница